FindTrial
Sign In

A study to compare the effects of Bupivacaine with Lignocaine and Ropivacaine with Lignocaine in Brachial Plexus Block.

Ultrasound Guided Supraclavicular Brachial Plexus Block: Comparative study of Bupivacaine with Lignocaine and Ropivacaine with Lignocaine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035536
Enrollment
66
Registered
2021-08-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 4- Measurement and Monitoring

Interventions

Intervention1: Bupivacaine and Lignocaine: 15 ml of 0.5% plain Bupivacaine is mixed with 15 ml of 0.2% Lignocaine Adrenaline for Supraclavicular Brachial Plexus Block Control Intervention1: Ropivacain

Sponsors

Shyamaldip Gurung
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA Grade 1 & 2 undergoing surgery of upper limb.

Exclusion criteria

Exclusion criteria: 1.Patients refusal/ Uncooperative patients 2.Patients having diabetes, hypertension, neuropathy, peripheral nerve injury. 3.Pregnant and lactating patients. 4.Patients on anticoagulants or bleeding disorders. 5.Patients with history of hypersensitivity to amide group of local anaesthetic agents.

Design outcomes

Primary

MeasureTime frame
Onset time of sensory and motor block. Timepoint: Assessment at 5 minutes, 10 minutes, 15 minutes and 20 minutes.—

Secondary

MeasureTime frame
Duration of postoperative analgesia Timepoint: Assessment at 2 hours, 4 hours and 6 hours.—

Countries

India

Contacts

Public ContactProf Kh Maniram Singh

Regional Institute of Medical Sciences

drmram6@gmail.com8259055986

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026